MRSA admission screening in a low prevalence setting - Much ado about nothing?

Swiss Medical Weekly

Volumn 141, Issue JULY, 2011, Pages

  Witteck, Andrea ^a   Rettenmund, Gabriela ^a   Schlegel, Matthias ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Admission screening; Hand hygiene; Low prevalence setting; MRSA; Number needed to isolate; Number needed to screen; Pre emptive isolation; Risk factors; Screening sites; Surveillance

Indexed keywords

CEFOXITIN;

ADULT; ARTICLE; AXILLARY SWAB; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ASSESSMENT; DIABETES MELLITUS; DIALYSIS; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; INGUINAL SWAB; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NOSE SMEAR; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; SCREENING; THROAT CULTURE; TRACHEOTOMY; URINALYSIS; URINARY CATHETER; WOUND; WOUND SWAB; GENETICS; INJURY; MASS SCREENING; METHODOLOGY; MICROBIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STANDARD; STAPHYLOCOCCUS INFECTION; SWITZERLAND; TIME;

GENOTYPE; HUMANS; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT ADMISSION; PATIENT ISOLATION; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SWITZERLAND; TIME FACTORS; WOUNDS AND INJURIES;

EID: 80052210902     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13217     Document Type: Article

References (33)

1. Diekema DJ, Pfaller Ma, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M; SENTRY Participants Group. Survey of infections due to Staphylococcus species: frequency of occurence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin Amercia, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S114-132.
2. Gould IM. The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2005;61(4):277-82. (Pubitemid 43009071)
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53-9. (Pubitemid 36099097)
4. Bradley SF, Terpenning MS, Ramsey MA, Zarins LT, Jorgensen KA, Sottile WS, Schaberg DR, Kauffman CA. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;115(6):417-22.
5. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, Farr BM. Control of methicillin-resistant Staphylococcus aureus in a university hospital one decade later. Infect Control Hosp Epidemiol. 1995;16(12):686-96.
6. Marschall J, Mühleman K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol. 2006;27(11):1206-12. (Pubitemid 44807464)
7. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Handcock GA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;114(2):107-12.
8. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776-82. (Pubitemid 39244289)
9. EARSS (European Antimicrobial Resistance Surveillance System). Proportion of MRSA isolates in participating countries in 2008. Available at: http://www.rivm.nl/earss/database/
10. Swiss Centre for Antibiotic resistance. Antibiotic resistance data 2008: Oxacillin-resistance of Staphylococcus aureus. Available at: http://www.anresis.ch/de/index.html
11. Diekema DJ, Edmond MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis. 2007;44(8):1101-7. (Pubitemid 46580282)
12. Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus: Quantifying the effects of interventions and rapid diagnostic testing. PNAS. 2006;103(14):5620-5.
13. Wernitz MH, Swidsinski S, Weist K, Sohr D, Witte W, Franke KP, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect. 2005;11(6):457-65. (Pubitemid 40744392)
14. Peterson LR, Diekema DJ. To screen or not to screen for Methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010;48(3):683-9.
15. Wenzel RP, Bearman G, Edmond MB. Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol. 2008;29:1012-8.
16. Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56(4):321-32.
17. Jones G, Sutton JK, Aplin S, Browning D. How many patients do you need to screen for methicillin-resistant Staphylococcus aureus to find a positive? Results from a screening programme in a UK teaching hospital. Clin Microbiol Infect. 2010;16(S2):S46.
18. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillinresistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43(8):971-8. (Pubitemid 44631095)
19. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149-57. (Pubitemid 351398429)
20. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003;290(14):1899-905. (Pubitemid 37430607)
21. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control. 2009;37(2):85-93.
22. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess. 2003;7(39):1-194.
23. Mathews AA, Thomas M, Appalaraju B, Jayalakshmi J. Evaluation and comparison of tests to detect methicillin resistant S. aureus. Indian J Pathol Microbiol. 2010;53(1):79-82.
24. Brown DF, Edwards DI, Hawkey PM, Morrison D, Ridgway GL, Towner KJ, Wren MW on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother. 2005;56(6):1000-8.
25. Fleisch F, Oechslin EC, Gujer AR, Ritzler E, Imhof A, Ruef C, Reinhart WH. Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland. Infection. 2005;33(4):273-7. (Pubitemid 41152189)
26. Edmond MB, Lyckholm L, Diekema DJ. Ethical implications of active surveillance cultures and contact precautions for controlling multidrug resistant organisms in the hospital setting. Public Health Ethics. 2008;1:235-45.
27. Sax H, Allegranzi B, Chraiti MN, Boyce J, Larson E, Pittet D. The World Health Organization hand hygiene observation method. Am J Infect Control. 2009;37(10):827-34.
28. Bühlmann M, Bögli-Stuber K, Droz S, Mühlemann K. Rapid screening for carriage of Methicillin-resistant Staphylococcus aureus by polymerase chain reaction and associated costs. J Clin Microbiol. 2008;46(7):2151-4.
29. Swiss-Noso 12/1995; Band 2, Nummer 4. Methizillin-resistenter S. aureus: Aktuelle Situation und Bedeutung. Available at: http://www.chuv.ch/swiss-noso/ cd24a1.htm
30. Mertz D, Reno F, Periat N, Zimmerli M, Battegay M, Flückiger U, Widmer AF. Exclusive Staphylococcus aureus throat cariage. Arch Intern Med. 2009;169(2):172-8.
31. Robicsek A, Beaumont JL, Paule SM, Hacek DM, Thomson RB Jr, Kaul KL, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148 (6):409-18. (Pubitemid 351665440)
32. Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-reistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol. 2007;28(3):249-60. (Pubitemid 46480722)
33. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000;356:1307-12.